BDMS-R.BK
Company Description
Bangkok Dusit Medical Services Public Company Limited, along with its affiliated entities, primarily operates and manages hospitals. The company oversees six distinct hospital networks: the Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, and Royal Hospital Group. In addition to core healthcare services, it offers comprehensive clinical wellness programs. Its business activities also span numerous other sectors, including hotel and restaurant operations, and the sale of health and cosmetic items. BDMS provides a diverse range of services, such as accounting, health insurance, laboratory testing, investment management, information technology, professional training, specialized skin and aesthetics telemedicine, genome sequencing, insurance brokerage, and air medical transportation. The company also handles facility, property, and asset management. Furthermore, it is involved in the production and distribution of medicines and pharmaceutical products. Its portfolio also extends to e-commerce and real estate ventures. The company maintains a substantial footprint, operating 47 hospitals across Thailand and Cambodia. Established in 1969, Bangkok Dusit Medical Services Public Company Limited is based in Bangkok, Thailand.
Track Record
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 111.51B | 107.87B | 100.85B | 91.93B | 74.45B | 68.07B | 82.72B | 78.42B | 71.93B | 67.99B | 62.86B | 56.05B |
| Net Income | 15.85B | 15.99B | 14.38B | 12.61B | 7.94B | 7.21B | 15.52B | 9.19B | 10.22B | 8.39B | 7.92B | 7.39B |
| EPS | 1.00 | 1.01 | 0.90 | 0.79 | 0.50 | 0.45 | 0.99 | 0.59 | 0.66 | 0.54 | 0.52 | 0.48 |
| Free Cash Flow | 13.03B | 11.28B | 12.53B | 15.19B | 10.19B | 5.03B | 6.55B | 7.11B | (4.67B) | 3.47B | 6.53B | 2.37B |
| FCF / Share | 0.82 | 0.71 | 0.79 | 0.96 | 0.64 | 0.32 | 0.42 | 0.46 | -0.30 | 0.22 | 0.42 | 0.15 |
| Operating CF | 23.45B | 22.96B | 20.78B | 20.27B | 14.56B | 11.68B | 14.55B | 14.80B | 10.93B | 12.45B | 12.87B | 10.38B |
| Total Assets | 157.96B | 151.51B | 143.60B | 141.54B | 128.45B | 136.05B | 133.66B | 133.50B | 122.63B | 106.94B | 102.33B | 93.23B |
| Total Debt | 17.49B | 18.36B | 18.13B | 23.59B | 18.83B | 24.25B | 24.43B | 39.95B | 39.34B | 31.90B | 30.00B | 31.61B |
| Cash & Equiv | 6.34B | 7.37B | 7.79B | 12.67B | 10.93B | 19.67B | 4.70B | 5.03B | 5.09B | 4.22B | 5.53B | 3.62B |
| Book Value | 105.89B | 100.04B | 95.24B | 89.88B | 83.85B | 87.91B | 83.81B | 70.32B | 63.07B | 55.72B | 53.68B | 46.78B |
| Return on Equity | 0.15 | 0.16 | 0.15 | 0.14 | 0.09 | 0.08 | 0.19 | 0.13 | 0.16 | 0.15 | 0.15 | 0.16 |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 28.18B | 28.45B | 28.24B | 26.73B | 28.08B | 27.40B | 28.15B | 25.70B | 26.61B | 26.34B | 26.42B | 24.08B |
| Net Income | 4.06B | 3.69B | 4.32B | 3.49B | 4.35B | 4.33B | 4.25B | 3.33B | 4.07B | 3.95B | 3.89B | 3.05B |
| EPS | 0.26 | 0.23 | 0.27 | 0.22 | 0.27 | 0.27 | 0.27 | 0.21 | 0.26 | 0.25 | 0.24 | 0.19 |
| Free Cash Flow | 4.82B | 2.01B | 3.37B | 2.55B | 4.40B | 560.83M | 3.28B | 2.34B | 5.15B | 1.70B | 2.81B | 3.53B |
| FCF / Share | 0.30 | 0.13 | 0.21 | 0.16 | 0.28 | 0.04 | 0.21 | 0.15 | 0.32 | 0.11 | 0.18 | 0.22 |
| Operating CF | 6.56B | 4.25B | 6.27B | 5.07B | 7.77B | 4.32B | 6.18B | 4.95B | 7.57B | 3.95B | 5.35B | 5.48B |
| Total Assets | 160.69B | 157.96B | 152.89B | 151.57B | 154.21B | 151.51B | 148.35B | 144.72B | 147.95B | 143.60B | 139.89B | 138.66B |
| Total Debt | 14.02B | 25.10B | 18.66B | 16.42B | 15.89B | 18.36B | 19.69B | 15.69B | 16.69B | 18.13B | 19.88B | 18.18B |
| Cash & Equiv | 7.38B | 6.34B | 5.70B | 5.32B | 9.06B | 7.37B | 9.03B | 7.14B | 11.34B | 7.79B | 8.22B | 10.44B |
| Book Value | 110.19B | 105.89B | 100.21B | 101.55B | 104.59B | 100.04B | 95.99B | 97.52B | 99.71B | 95.24B | 90.10B | 91.78B |
| Return on Equity | 0.04 | 0.03 | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 | 0.03 |